Industry Growth Insights published a new data on “Stem Cell Umbilical Cord Blood Market”. The research report is titled “Stem Cell Umbilical Cord Blood Market research by Types (Public Cord Blood Banks, Private Cord Blood Banks), By Applications (Cancer/ Oncology Diseases, Chronic Leukemia, Myelodysplastic Syndrome, Blood Diseases, Beta Thalassemia, Sickle Cell Disease, Wiskott-Aldrich, Hurler Syndrome, Sanfilippo Syndrome), By Players/Companies Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation, Neostem”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Umbilical Cord Blood Market Research Report
By Type
Public Cord Blood Banks, Private Cord Blood Banks
By Application
Cancer/ Oncology Diseases, Chronic Leukemia, Myelodysplastic Syndrome, Blood Diseases, Beta Thalassemia, Sickle Cell Disease, Wiskott-Aldrich, Hurler Syndrome, Sanfilippo Syndrome
By Companies
Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation, Neostem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Umbilical Cord Blood Market Report Segments:
The global Stem Cell Umbilical Cord Blood market is segmented on the basis of:
Types
Public Cord Blood Banks, Private Cord Blood Banks
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer/ Oncology Diseases, Chronic Leukemia, Myelodysplastic Syndrome, Blood Diseases, Beta Thalassemia, Sickle Cell Disease, Wiskott-Aldrich, Hurler Syndrome, Sanfilippo Syndrome
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Advanced Cell Technology
- California Stem Cell
- Cytori Therapeutics
- Mesoblast Limited
- Opexa Therapeutics
- Athersys
- Geron Corporation
- Neostem
Highlights of The Stem Cell Umbilical Cord Blood Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Public Cord Blood Banks
- Private Cord Blood Banks
- By Application:
- Cancer/ Oncology Diseases
- Chronic Leukemia
- Myelodysplastic Syndrome
- Blood Diseases
- Beta Thalassemia
- Sickle Cell Disease
- Wiskott-Aldrich
- Hurler Syndrome
- Sanfilippo Syndrome
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Umbilical Cord Blood Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Stem cell umbilical cord blood is a rich source of stem cells that can be used to treat a variety of diseases. Cord blood is collected from the umbilical cord shortly after birth and contains immature cells that are able to develop into any type of cell in the body. This makes it an excellent source for treating diseases such as leukemia, lymphoma, and other blood disorders.
Some of the major players in the stem cell umbilical cord blood market are Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics, Athersys, Geron Corporation, Neostem.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Umbilical Cord Blood Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Umbilical Cord Blood Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Umbilical Cord Blood Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Umbilical Cord Blood Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Umbilical Cord Blood Market Size & Forecast, 2018-2028
4.5.1 Stem Cell Umbilical Cord Blood Market Size and Y-o-Y Growth
4.5.2 Stem Cell Umbilical Cord Blood Market Absolute $ Opportunity
Chapter 5 Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Stem Cell Umbilical Cord Blood Market Size Forecast by Type
5.2.1 Public Cord Blood Banks
5.2.2 Private Cord Blood Banks
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Stem Cell Umbilical Cord Blood Market Size Forecast by Applications
6.2.1 Cancer/ Oncology Diseases
6.2.2 Chronic Leukemia
6.2.3 Myelodysplastic Syndrome
6.2.4 Blood Diseases
6.2.5 Beta Thalassemia
6.2.6 Sickle Cell Disease
6.2.7 Wiskott-Aldrich
6.2.8 Hurler Syndrome
6.2.9 Sanfilippo Syndrome
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Umbilical Cord Blood Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Umbilical Cord Blood Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Stem Cell Umbilical Cord Blood Analysis and Forecast
9.1 Introduction
9.2 North America Stem Cell Umbilical Cord Blood Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Stem Cell Umbilical Cord Blood Market Size Forecast by Type
9.6.1 Public Cord Blood Banks
9.6.2 Private Cord Blood Banks
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Stem Cell Umbilical Cord Blood Market Size Forecast by Applications
9.10.1 Cancer/ Oncology Diseases
9.10.2 Chronic Leukemia
9.10.3 Myelodysplastic Syndrome
9.10.4 Blood Diseases
9.10.5 Beta Thalassemia
9.10.6 Sickle Cell Disease
9.10.7 Wiskott-Aldrich
9.10.8 Hurler Syndrome
9.10.9 Sanfilippo Syndrome
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Stem Cell Umbilical Cord Blood Analysis and Forecast
10.1 Introduction
10.2 Europe Stem Cell Umbilical Cord Blood Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Stem Cell Umbilical Cord Blood Market Size Forecast by Type
10.6.1 Public Cord Blood Banks
10.6.2 Private Cord Blood Banks
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Stem Cell Umbilical Cord Blood Market Size Forecast by Applications
10.10.1 Cancer/ Oncology Diseases
10.10.2 Chronic Leukemia
10.10.3 Myelodysplastic Syndrome
10.10.4 Blood Diseases
10.10.5 Beta Thalassemia
10.10.6 Sickle Cell Disease
10.10.7 Wiskott-Aldrich
10.10.8 Hurler Syndrome
10.10.9 Sanfilippo Syndrome
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Stem Cell Umbilical Cord Blood Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Stem Cell Umbilical Cord Blood Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Stem Cell Umbilical Cord Blood Market Size Forecast by Type
11.6.1 Public Cord Blood Banks
11.6.2 Private Cord Blood Banks
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Stem Cell Umbilical Cord Blood Market Size Forecast by Applications
11.10.1 Cancer/ Oncology Diseases
11.10.2 Chronic Leukemia
11.10.3 Myelodysplastic Syndrome
11.10.4 Blood Diseases
11.10.5 Beta Thalassemia
11.10.6 Sickle Cell Disease
11.10.7 Wiskott-Aldrich
11.10.8 Hurler Syndrome
11.10.9 Sanfilippo Syndrome
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Stem Cell Umbilical Cord Blood Analysis and Forecast
12.1 Introduction
12.2 Latin America Stem Cell Umbilical Cord Blood Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Stem Cell Umbilical Cord Blood Market Size Forecast by Type
12.6.1 Public Cord Blood Banks
12.6.2 Private Cord Blood Banks
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Stem Cell Umbilical Cord Blood Market Size Forecast by Applications
12.10.1 Cancer/ Oncology Diseases
12.10.2 Chronic Leukemia
12.10.3 Myelodysplastic Syndrome
12.10.4 Blood Diseases
12.10.5 Beta Thalassemia
12.10.6 Sickle Cell Disease
12.10.7 Wiskott-Aldrich
12.10.8 Hurler Syndrome
12.10.9 Sanfilippo Syndrome
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Stem Cell Umbilical Cord Blood Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Stem Cell Umbilical Cord Blood Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Stem Cell Umbilical Cord Blood Market Size Forecast by Type
13.6.1 Public Cord Blood Banks
13.6.2 Private Cord Blood Banks
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Stem Cell Umbilical Cord Blood Market Size Forecast by Applications
13.10.1 Cancer/ Oncology Diseases
13.10.2 Chronic Leukemia
13.10.3 Myelodysplastic Syndrome
13.10.4 Blood Diseases
13.10.5 Beta Thalassemia
13.10.6 Sickle Cell Disease
13.10.7 Wiskott-Aldrich
13.10.8 Hurler Syndrome
13.10.9 Sanfilippo Syndrome
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Umbilical Cord Blood Market: Competitive Dashboard
14.2 Global Stem Cell Umbilical Cord Blood Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Advanced Cell Technology
14.3.2 California Stem Cell
14.3.3 Cytori Therapeutics
14.3.4 Mesoblast Limited
14.3.5 Opexa Therapeutics
14.3.6 Athersys
14.3.7 Geron Corporation
14.3.8 Neostem
